Pearson Medical Technologies specializes in advanced pharmacy automation solutions. Their products include unit dose packaging equipment and m:Print® Bar Code Labeling Software, aimed at enhancing patient outcomes and streamlining pharmacy operations.

Pearson Medical Technologies

Cardinal Health, Inc. operates as an integrated healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home. The company operates in two segments, Pharmaceutical and Medical. The Pharmaceutical segment distributes branded and generic pharmaceutical, specialty pharmaceutical, and over-the-counter healthcare and consumer products. The segment also provides services to pharmaceutical manufacturers and healthcare providers for specialty pharmaceutical products; operates nuclear pharmacies and radiopharmaceutical manufacturing facilities; repackages generic pharmaceuticals and over-the-counter healthcare products; and offers medication therapy management and patient outcomes services to hospitals, other healthcare providers, and payers, as well as provides pharmacy management services to hospitals. The Medical segment manufactures, sources, and distributes Cardinal Health branded medical, surgical, and laboratory products and devices that include exam and surgical gloves; needles, syringe, and sharps disposals; compressions; incontinences; nutritional delivery products; wound care products; single-use surgical drapes, gowns, and apparels; fluid suction and collection systems; urology products; operating room supply products; and electrode product lines. The segment also distributes a range of national brand products, including medical, surgical, and laboratory products; provides supply chain services and solutions to hospitals, ambulatory surgery centers, clinical laboratories, and other healthcare providers; and assembles and sells sterile, and non-sterile procedure kits. The company was incorporated in 1979 and is headquartered in Dublin, Ohio.

Robert Walter

Cardinal Health, Inc.

McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, International, Medical-Surgical Solutions, and Prescription Technology Solutions (RxTS). The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar, and over-the-counter pharmaceutical drugs and other healthcare-related products. This segment also provides practice management, technology, clinical support, and business solutions to community-based oncology and other specialty practices; and consulting, outsourcing, technological, and other services, as well as sells financial, operational, and clinical solutions to pharmacies. The International segment offers distribution and services to wholesale, institutional, and retail customers in 13 European countries and Canada. The Medical-Surgical Solutions segment provides medical-surgical supply distribution, logistics, and other services to healthcare providers. The RxTS segment serves biopharma and life sciences partners and patients to address medication challenges for patients throughout their journeys; connects pharmacies, providers, payers, and biopharma companies to deliver innovative access and adherence solutions; and provides third-party logistics and wholesale distribution support solutions. McKesson Corporation was founded in 1833 and is headquartered in Irving, Texas.

Charles Olcott

Nicholas Dooda

McKesson Corporation

Nuscriptrx provides data related to Sydney lottery results and aims to enhance the prediction of winning numbers. The website offers daily updates on lottery outcomes.

Metric
Company Name	Pearson Medical Technologies	Cardinal Health, Inc.	McKesson Corporation	Nuscriptrx
Symbol		CAH	MCK
MSH ID	COM:PEARSONMEDICAL	COM:CARDINALHEALTH	COM:MCKESSON	COM:NUSCRIPTRX
Market	PRIVATE	STOCKS	STOCKS	PRIVATE
Sector	Healthcare & Health Services	Healthcare	Healthcare	Consumer Services
Industry	Pharmacy Automation	Medical - Distribution	Medical - Distribution	Gaming
Country	US	US	US	ID
Stage				Venture Round
Employee Count		47.04K	45K
Website	pearsonmedical.com	cardinalhealth.com	mckesson.com	nuscriptrx.com
LinkedIn
Founders

Metric
Market Cap	23.28B	76.12B
Enterprise Value
Monthly Web Traffic		2.42M	232
Web Traffic Growth		0.03
Valuation
Raised Capital			3.85M

Metric
Revenue	226.83B	308.95B
Revenue (LTM)
Revenue (NTM)
Gross Profit	7.41B	12.20B
EBITDA	1.24B	4.56B
Operating Income	1.24B	3.93B
Net Income	852M	3.00B
EPS	3.48	22.54
Diluted EPS	3.45	22.39
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin	0.03	0.04
Operating Profit Margin	0.01	0.01
EBITDA Margin	0.01	0.01
Net Profit Margin	0.00	0.01
Return on Equity	-0.17	7.32
Return on Assets	0.02	0.05
Return on Capital Employed	0.17	0.27

PEAR

COM:PEARSONMEDICAL

Pearson Medical Technologies

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio	39.78	19.52
P/B Ratio	-7.37	-37.24
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio	0.13	0.26
EV Multiple	9.86	16.72

Metric
Days Sales Outstanding	19.91	28.20
Days Payables Outstanding	59.85	61.27
Days Inventory Outstanding	32.24	31.00
Operating Cycle	52.14	58.62
Cash Conversion Cycle	-6.21	-3.22
Asset Turnover	5.03	4.58

Metric
Operating Cash Flow	3.76B	4.31B
Free Cash Flow	3.25B	3.63B
Cash Flow to Debt	0.84	0.75
Operating Cash Flow/Sales	0.02	0.01
Free Cash Flow Yield	0.13	0.06

Metric
Cash & Equivalents	5.13B	4.58B
Accounts Receivable	-996M	-2.95B
Inventory	14.96B	21.14B
Goodwill		10.13B
Debt to Capitalization	3.71	1.52
Debt to Assets	0.10	0.11
Current Ratio	0.98	0.93
Quick Ratio	0.56	0.51

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue	0.00	0.00
R&D to Revenue
SG&A to Revenue		0.05